The company aims to broaden diagnostic capabilities across dozens of biomarkers. Early testers say the system provides unmatched clarity. The funding accelerates rollout plans.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
